Tesla shifts AI strategy, ending Dojo project and partnering with Samsung for next-gen self-driving chips amid challenges in electric vehicle sales and robotaxi rollout.
Krispy Kreme reports massive Q2 loss, triggering a turnaround plan focused on cost reduction and operational efficiency.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Tesla shifts AI strategy, ending Dojo project and partnering with Samsung for next-gen self-driving chips amid challenges in electric vehicle sales and robotaxi rollout.
Krispy Kreme reports massive Q2 loss, triggering a turnaround plan focused on cost reduction and operational efficiency.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.